Adjuvant chemotherapy is associated with improved survival in patients with nodal metastases after neoadjuvant therapy and esophagectomy.

Conclusions: In a large, propensity-matched cohort, adjuvant chemotherapy was associated with significantly improved survival for patients with node-positive esophageal adenocarcinoma after neoadjuvant therapy and complete resection. This finding supports the use of adjuvant therapy for patients with node-positive adenocarcinoma after neoadjuvant therapy and surgery. PMID: 31372291 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31372291?dopt=Abstract

Source: Journal of Thoracic Disease - August 4, 2019 Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research